Blood and brain-marker study after a first psychotic episode
Treatments studied
Part of Mental health clinical trials.
This study looks at whether special body and brain markers can predict how a person’s symptoms change over two years after a first psychotic episode. It may also help doctors understand who responds better to treatment, so future care can be more personalized.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 to 30 years old and had a first episode of psychosis.
- You can sign the consent form (if under 18, a parent/guardian consents too).
- You have not started or increased antipsychotic, antidepressant, or thymic (thymus-related) treatment in the past month.
- Your psychosis is not caused by a medical (organic) condition or by drugs/substance use or withdrawal with severe dependence.
- You can have MRI scanning (no MRI safety problems).
- You are not pregnant or breastfeeding, and you are not under court-ordered protection/guardianship/deprivation of liberty.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses brain scans to find markers that can predict how well antipsychotic medications work in people having their first episode of psychosis. It aims to help doctors choose the right treatment earlier.
This study examines the brain in people having their first episode of psychosis (like hearing voices or strong false beliefs) to understand more about schizophrenia and related conditions. It involves MRI scans and other tests over one year.
This study looks at how psychosis symptoms and development change over time in children and teens. It may help doctors better understand different patterns of illness and how to support young people with these disorders.
This trial looks at people having a first psychotic episode who have not yet taken anti-psychotic medicine. It aims to see whether an early support approach can help, before other treatments become necessary.
This study looks at people with early psychosis who are about to start a new antipsychotic medication. It uses brain scans to understand how these medications work. If you are starting a new antipsychotic or changing your dose, this trial may be for you.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
Hear when a new First Episode Psychosis (FEP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.